Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-18

Clinical Trial Update: MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MISOBEST (orally misoprostol solution) to misoprostol tablet for induction of labor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angusta
  • MISOBEST (misoprostol solution)

Snippet

Sponsor: Karolinska Institutet | Conditions: Induced Vaginal Delivery | Phase 3 | Status: COMPLETED